Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes EP News Bureau Mar 20, 2025 Phase 3 SURPASS programme demonstrated that Mounjaro, whether used alone or with other diabetes medications, reduced A1C by up to…
USV launches Xenia: Empagliflozin and its combinations for diabetes care in India EP News Bureau Mar 18, 2025 With the loss of exclusivity, Empagliflozin and its combinations are now available at one-fifth the cost, enhancing affordability
Lupin acquires Huminsulin from Eli Lilly EP News Bureau Dec 31, 2024 Lupin has been marketing the Huminsulin range of products through existing distribution and promotion agreements with Lilly, India…
